Device and method to maintain vascularization near implant

Details for Australian Patent Application No. 2002339849 (hide)

International Classifications

Event Publications

27 February 2003 Complete Application Filed

Priority application(s): 09/949,575 11.09.01 US

19 June 2003 Application Open to Public Inspection

Published as AU-B-2002339849

27 November 2008 Assignment before Grant

Nephros Therapeutics; The Regents of the University of Michigan The application has been assigned to The Regents of the University of Michigan; Nephrion, Inc. 2003

12 November 2009 Application Accepted

Published as AU-B-2002339849

11 February 2010 Amendment Made

The nature of the amendment is: Amend the coapplicant name from Nephrion, Inc. to Cytopherx, Inc.

1 April 2010 Application for Amendment

The nature of the amendment is: Amend the co-inventor from Humes, Davis H. to Humes, David H.. Address for service in Australia - PIZZEYS Level 14, ANZ Centre 324 Queen Street Brisbane QLD 4000 2003 2003257329 2,4,5-trisubstituted imidazoles and their use as antimicrobial agents Lorus Therapeutics Inc. The nature of the amendment is as shown in the statement(s) filed 18 Feb 2010. Address for service in Australia - Lesicar Perrin 58 Rundle Street (cnr The Parade West) Kent Town SA 5067

8 July 2010 Amendment Made

The nature of the amendment is: Amend the coinventor from Humes, Davis H. to Humes, David H. 2003

15 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.